
Paznib 400mg Tablet
Salt Composition: Pazopanib
Expiry Date: 01/2028
Inclusive of all taxes
30 Tablet
About The Product
Kidney Cancer
Paznib 400mg Tablet is an anticancer medicine that belongs to the group of medicines known as protein kinase inhibitors. It is prescribed in the treatment of renal cell carcinoma (kidney cancer) and advanced soft tissue sarcoma. The active ingredient of this anticancer medicine is Pazopanib. It is an antineoplastic drug, which means it stops cancer cells from spreading to other organs of the body.
Side Effects
- Like most anticancer drugs, Paznib 400mg Tablet may cause some adverse effects on the body during the treatment.
- These can vary from mild to severe depending on the dose and the patient’s health condition.
- Common side effects include: Hypertension Color change of hair and skin High glucose levels Difficulty in breathing Decrease in weight and appetite Diarrhea Nausea and vomiting Muscle and joint pain Headache Tiredness Some serious side effects: Frequent Infections Bleeding from the anus and mouth Hypothyroidism Heart problems Interstitial lung disease Inform your doctor immediately if you experience any persistent or unusual side effects.
How To Use
- The dosage and treatment duration with Paznib 400mg Tablet is determined by the doctor as per the stage & type of cancer and the overall patient's health condition.
- It should be taken orally with water and should not be chewed, crushed, or broken.
- This capsule should be taken at least two hours after a meal or one hour before a meal at the fix time every day to get effective results.
- Don't miss a dose or overdose on the medicine.
How It Works
Paznib 400mg Tablet is an anticancer medicine that belongs to the class of protein kinase inhibitors. This medicine works by binding and blocking the activity of the enzyme receptors (tyrosine kinase) that are responsible for the multiplication of the cancerous cells in the body.
Paznib Tablet also stops the growth of new blood vessels within the tumor. It effectively slows down the progress.
Safety Advice
Missed Doses
- It is advised not to miss any scheduled dosage of Paznib 400mg Tablet.
- In case you miss a dose, consult your doctor immediately.
- Don't overdose to compensate for the missed one.
- Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
- It is advised not to drink grapefruit juice during the treatment with Paznib 400mg Tablet, as there is the possibility that it may increase the severity of the side effects of the medicine.
- Always use effective contraception when any of the partners are undergoing treatment with Paznib 400mg Tablet or at least 2 weeks after the last dose of the medicine to prevent pregnancy.
FAQs
In case you forgot to take a dose of Paznib Tablet, consult your doctor immediately.
It is advised not to overdose for a missed dose of medicine.
Reference
1. Bukowski, R.
M., Yasothan, U., & Kirkpatrick, P. (2010).
Pazopanib. Nature reviews Drug discovery, 9(1), 17-18.
2. Miyamoto, S., Kakutani, S., Sato, Y., Hanashi, A., Kinoshita, Y., & Ishikawa, A.
(2018). Drug review: pazopanib.
Japanese Journal of Clinical Oncology, 48(6), 503-513. 3.
Sonpavde, G., & Hutson, T. E.
(2007). Pazopanib: a novel multitargeted tyrosine kinase inhibitor.
Current oncology reports, 9(2), 115-119. 4.
Schutz, F. A., Choueiri, T.
K., & Sternberg, C. N.
(2011). Pazopanib: Clinical development of a potent anti-angiogenic drug.
Critical reviews in oncology/hematology, 77(3), 163-171. 5.
Hutson, T. E., Davis, I.
D., Machiels, J. P.
H., De Souza, P. L., Rottey, S., Hong, B.
F., ... & Figlin, R. A.
(2010). Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma.
Journal of Clinical Oncology, 28(3), 475-480. 6.
Motzer, R. J., Hutson, T.
E., Cella, D., Reeves, J., Hawkins, R., Guo, J., ... & Choueiri, T. K.
(2013). Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
New England Journal of Medicine, 369(8), 722-731.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
